CTDP-001

N/A

Report date: 2025/06/11 10:57:32
NME

Base Information

Drug NameCTDP-001
Drug Alias Namedopamine active transport inhibitors (Chronos Therapeutics)CTDP-001CT-005404
ClassificationSmall molecules
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)FatigueDisorders of Excessive Somnolence +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesTheraCryf PLCChronos Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)FatigueDisorders of Excessive Somnolence +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A